Although H-score analysis did not reach statistical significance ( Supplementary Figure 3A ), the trends support enhanced pathways inhibition.
← all excerpts
Dual PI3K and HDAC inhibitor, CUDC-907, effectively inhibits endometrial cancer growth <i>in vitro</i> and <i>in vivo</i>.
1
—
—